Stephen Machatha
Fortuna: 388 518 $ al 31/05/2026
Fortuna: 388 518 $ al 31/05/2026
Stephen G.
Machatha worked at Aldeyra Therapeutics, Inc. from 2016 to 2026, serving as Chief Development Officer from 2021 to 2026.
Dr. Machatha completed undergraduate, graduate, and doctorate degrees at the University of Arizona.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 13/04/2026 | 222.010 ( 0,37 % ) | 388 518 $ | 31/05/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| ALDEYRA THERAPEUTICS, INC. | Corporate Officer/Principal | 31/03/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Aldeyra Therapeutics, Inc.
Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
University of Arizona
University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.